Merck (XPAR:MRK) Days Inventory : 147.22 (As of Dec. 2023)

View and export this data going back to 1946. Start your Free Trial

What is Merck Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Merck's Average Total Inventories for the three months ended in Dec. 2023 was €5,788 Mil. Merck's Cost of Goods Sold for the three months ended in Dec. 2023 was €3,587 Mil. Hence, Merck's Days Inventory for the three months ended in Dec. 2023 was 147.22.

The historical rank and industry rank for Merck's Days Inventory or its related term are showing as below:

XPAR:MRK' s Days Inventory Range Over the Past 10 Years
Min: 124.36 Med: 139.83 Max: 173.42
Current: 136.68

During the past 13 years, Merck's highest Days Inventory was 173.42. The lowest was 124.36. And the median was 139.83.

XPAR:MRK's Days Inventory is ranked better than
59.71% of 973 companies
in the Drug Manufacturers industry
Industry Median: 157.9 vs XPAR:MRK: 136.68

Merck's Days Inventory increased from Dec. 2022 (140.10) to Dec. 2023 (147.22). It might indicate that Merck's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Merck's Inventory Turnover for the three months ended in Dec. 2023 was 0.62.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Merck's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.43.

Merck Days Inventory Historical Data

The historical data trend for Merck's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Days Inventory Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

171.49

162.15

148.82

120.46

140.82

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															140.10	137.56	134.50	128.11	147.22

Competitive Comparison of Merck's Days Inventory

For the Drug Manufacturers - General subindustry, Merck's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Days Inventory distribution charts can be found below:

* The bar in red indicates where Merck's Days Inventory falls into.

Merck Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Merck's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (5579.984	+	5830.286)	/	2 )	/	14787.542	*	365
=	5705.135					/	14787.542	*	365
=	140.82

Merck's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (5744.747	+	5830.286)	/	2 )	/	3587.304	*	365 / 4
=	5787.5165					/	3587.304	*	365 / 4
=	147.22

Merck (XPAR:MRK) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Merck's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3587.304	/	5787.5165
	=	0.62

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Merck's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5787.5165	/	13415.71
	=	0.43

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Merck Days Inventory Related Terms

Thank you for viewing the detailed overview of Merck's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (XPAR:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XPAR:MRK) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany 6MK:Germany 6MK:Germany 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.